Loading insider details...
Beta
Latest Form 4 (Aug 7, 2026): Grant/Award of 2,000 LPCN shares, $4.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 7, 2026 | Lipocine Inc. (LPCN) | Grant/Award | 2,000 | $4.2K |
| Jun 23, 2026 | Adicet Bio, Inc. (ACET) | Grant/Award | 4,200 | n/a |
| Jun 17, 2026 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 3,135 | n/a |
| Jun 9, 2025 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,045 | n/a |
| Apr 21, 2025 | Adicet Bio, Inc. (ACET) | Grant/Award | 70,200 | n/a |
| Jul 2, 2024 | Akari Therapeutics Plc (AKTX) | Grant/Award | 5,000,000 | n/a |
| Jun 21, 2024 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 1,045 | n/a |
| Aug 25, 2023 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 500 | n/a |
| Aug 1, 2022 | Aprea Therapeutics, Inc. (APRE) | Grant/Award | 5,995 | n/a |
| Jun 5, 2020 | resTORbio, Inc. (TORC) | Grant/Award | 14,414 | n/a |